Filing Details
- Accession Number:
- 0001127602-12-001330
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-01-09 15:52:37
- Reporting Period:
- 2012-01-06
- Filing Date:
- 2012-01-09
- Accepted Time:
- 2012-01-09 15:52:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1318886 | K Eric Rowinsky | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-01-06 | 1,325 | $59.82 | 10,460 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-01-06 | 1,325 | $116.00 | 9,135 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-01-06 | 11,667 | $59.82 | 20,802 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-01-06 | 11,667 | $116.00 | 9,135 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2012-01-06 | 1,325 | $0.00 | 1,325 | $59.82 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2012-01-06 | 11,667 | $0.00 | 11,667 | $59.82 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-03-22 | 2020-03-22 | No | 4 | M | Direct |
23,333 | 2020-03-22 | No | 4 | M | Direct |
Footnotes
- Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities and Exchange Act of 1934.
- The stock options become exercisable in three (3) equal annual installments commencing one year after the grant date of 03/22/2010.